Company Filing History:
1 out of 2 
1 out of 2,692 
1 out of 1 Years Active: 1982-2003
Title: The Innovative Contributions of Daniel Cohen
Introduction
Daniel Cohen is a prominent inventor based in Paris, France. He has made significant contributions to the fields of biotechnology and pharmaceuticals. With a focus on cancer treatment, his work has led to the development of several important patents.
Latest Patents
Cohen holds 3 patents that showcase his innovative approach to medical science. His latest patents include groundbreaking research on nucleotide sequences, proteins, drugs, and diagnostic agents aimed at treating cancer. One of his notable inventions involves Tumor Suppressor Activated Pathway (TSAP) genes and the nucleotide sequences associated with them. This patent describes the mechanism by which TSAP 3 activates apoptosis, providing insights into potential cancer therapies. Additionally, he has developed pharmaceutical compositions and methods for preventing tumorigenesis. Another significant patent details a method and apparatus for apportioning a primary volume of fluid into multiple secondary volumes, utilizing a chamber designed for precise fluid management.
Career Highlights
Throughout his career, Daniel Cohen has worked with notable companies such as Bertin Et Cie and Thales Group. His experience in these organizations has allowed him to refine his skills and contribute to various innovative projects.
Collaborations
Cohen has collaborated with esteemed professionals in his field, including Yves Le Gall and Jean Dausset. These partnerships have further enriched his research and development efforts.
Conclusion
Daniel Cohen's contributions to the field of biotechnology and cancer treatment are noteworthy. His innovative patents and collaborations reflect his commitment to advancing medical science. His work continues to inspire future research and development in the industry.